NeoMend Gets $6M

NeoMend, a biotech company based in Irvine, California, has raised $6 million in a Series C round from an undisclosed VC, reports vw. Existing investors Prospect Venture Partners and Sanderling Ventures returned. http://www.neomendinc.com